
Using an innovative trial design to efficiently evaluate multiple interventions simultaneously. Research is in our DNA #remapcapfamily https://xitter.cf/t.co/xvsFGJlEiK
Joined March 2017
- Tweets526
- Following143
- Followers3.9K
- Likes529
remap-cap retweeted
The REMAP-CAP modular protocol was a master protocol paired with domain-specific appendices and was a substantial advance in trial infrastructure.
Prof. Steve Webb explains how this structure replaced the inefficiency of static, all-in-one protocols. With modularity, adding a new domain and operationalizing it, including data management, could be achieved in three or four weeks.
This design proved its worth during the COVID-19 pandemic, supporting efficient adaptation and robust evidence generation under real-world crisis constraints.
Learn more about the origins of REMAP-CAP on the latest episode of "In the Interim..." berryconsultants.com/resourc…
REMAP-CAP's @DerdeLennie adds her voice to a beautiful celebration of #InternationalDayofWomenandGirlsinScience 👇
This Post is from an account that no longer exists. Learn more
REMAP-CAP expanded immensely during the #COVID19 #pandemic, but in many regions it predates that period.
🇯🇵 @RemapCap Japan commenced in 2020 & has had an outsized impact on #clinicalresearch in the country, paving the way for other adaptive platform trials.
#10YearsREMAPCAP
🫁 Today we mark #WorldPneumoniaDay2024.
The #remapcapfamily has been tackling community-acquired #pneumonia for a decade now, and our joint efforts have positively impacted many lives around the world.
#10YearsREMAPCAP
#infectiousdiseases #clinicalresearch #covid19
Keeping patients, their families and the public engaged is a strength of REMAP-CAP.
🇵🇰 The Pakistani Patient & Public Involvement & Engagement group's 2024 summit gained national news coverage and presented networking opportunities.
👉 youtube.com/watch?v=3Lsgedtz…
#10YearsREMAPCAP
remap-cap retweeted
Empowering Patients - Revising Informed Consent Processes for Critical Care Trials in Pakistan
Our public group has worked with us to make informed consent for @MegaROXtrial and @remap_cap more culturally sensitive and relevant in the Pakistani context
remap-cap retweeted
What does being a pragmatic trial mean in South Asia?
We evaluated 3 international trials (@remap_cap @MegaROXtrial RECOVERY)
Absent post-discharge follow up and poor physician and public understanding of trials constrained their incorporation into usual care
Our friends at the Dutch hospital @UMCU_Intl highlight REMAP-CAP's exceptional contribution to tackling community-acquired #pneumonia & #COVID19 🫁
Read the article 👉 research.umcutrecht.nl/stori…
#10YearsREMAPCAP
@Lennie333 @MarcBonten @IenI_UMCUtrecht
REMAP-CAP team members attended the Federated Platform Trials meeting in Dublin organised by @ICCCTN, @ISARIC1 & @AcuteCareTrials.
The focus was on principles to enable platform #clinicaltrials to federate effectively, particularly in the field of #criticalcare.
remap-cap retweeted
Thank you to our fantastic ICU team on #Red4Research day for their ongoing support with Clinical Trials @Airways_3 @AbbruptTrial @GenomiccStudy @iRehabTrial @remap_cap ❤️
🇵🇰 @Zuedu is one of 7 sites in Pakistan currently participating in REMAP-CAP.
Its Patient and Public Involvement & Engagement group recently produced a great video explaining #clinicaltrials in Urdu and with locally relevant graphics.
Check it out 👉 youtube.com/watch?v=dCZqm6hW…
🚩 Major REMAP-CAP milestone: 14.000 patients have been enrolled in the trial globally.
A big THANK YOU to the whole #remapcapfamily for the dedication and commitment to improving outcomes for patients with community-acquired #pneumonia 👏🏻👏🏾👏🏼
#10YearsREMAPCAP
Attending the #ERSCongress2024? Join this postgrad course to hear @Lennie333 discuss the landscape of adaptive platform #clinicaltrials in #criticalcare and the REMAP-CAP trial 👇
@EuroRespSoc @UMCU_Intl @IenI_UMCUtrecht @EU_Commission
EU project sessions at the #ERSCongress2024
Join the experts on 7 September at 14:00 CEST for PG10 Postgraduate course Management of respiratory infection: lessons learnt from @Ecraid-Base clinical trials.
Find out more: k4.ersnet.org/prod/v2/Front/…
remap-cap retweeted
There was a lot of discussion around the presentation of the @remap_cap steroids for non-COVID community-acquired pneumonia domain results at #CCR24
Steve Webb from @anzicsctg & Scott Berry from @BerryConsultant discuss their findings
The data are presently unpublished
Those working on the REMAP-CAP trial in Europe are eligible for an attendance grant from @Ecraid. Follow the link below for details on how to apply 👇
This Post is from an account that no longer exists. Learn more
Professor Anthony Gordon, REMAP-CAP's UK Chief Investigator, has been awarded an MBE (Member of the Order of the British Empire) for his contribution to #criticalcare.
Congratulations on this important recognition, @agordonICU 👏
imperial.nhs.uk/about-us/new… @imperialcollege
🏁 @CritCareReviews Meeting 2024 begins tomorrow!
🚩 Among the 11 major trial results to be presented at #CCR24 are REMAP-CAP findings. Don't miss our exciting presentations.
▶️ Not attending? Watch the free livestream at criticalcarereviews.com/meet…
REMAP-CAP was highlighted by @ThwaitesGuy as "a trial that really matters". Watch his #ESCMIDGlobal presentation online 👇
This Post is from an account that no longer exists. Learn more
#CCR24 kicks off in 7 days! Don't miss the REMAP-CAP presentations:
💊 Statins Trial Review
💊 Ivermectin Trial Results
💊 Steroids Trial Results
Check out the full programme 👉 criticalcarereviews.com/meet…
Support @CritCareReviews 👉 criticalcarereviews.com/home…
remap-cap retweeted
how did it go?
impressive summary of @remap_cap findings
#PratoAnaes2024
@stephen_t_webb @pinkney_t @KBibbinsDomingo @jocalynclark @HughHemmings @TWSnelling @HeliScottpterDr @yeung_joyce
remapcap.org/publications




















